Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Quantum Biopharma ( (TSE:QNTM) ) has issued an update.
On May 21, 2025, Quantum BioPharma announced a partnership with BitGo Trust Company to securely manage and store its cryptocurrency assets, including Bitcoin, Solana, XRP, and DOGE coin. This collaboration with BitGo, known for its secure custody solutions, aligns with Quantum’s priorities for security and compliance as it expands its engagement with digital assets. The partnership is expected to enhance Quantum’s operational security and position in the digital finance sector.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative biotech solutions for neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. The company is engaged in the research and development of its lead compound, Lucid-MS, which targets multiple sclerosis. Quantum BioPharma also has strategic investments through its subsidiary, FSD Strategic Investments Inc., and retains a significant stake in Celly Nutrition Corp.
Average Trading Volume: 8,951
Technical Sentiment Signal: Sell
Current Market Cap: C$32.98M
For a thorough assessment of QNTM stock, go to TipRanks’ Stock Analysis page.